CoachP

Collection

Emerging research compounds

Compounds in clinical trials that aren't approved yet.

3 compounds

Educational only. A summary of published research, not medical advice or a recommendation. No doses are listed.

Emerging research compounds (3)

  • Retatrutide

    Investigational

    GLP-1 & weight-loss peptides · Large human trials

    An investigational once-weekly “triple agonist” that acts on the GIP, GLP-1 and glucagon receptors.

  • Survodutide

    Investigational

    GLP-1 & weight-loss peptides · Early or small human studies

    An investigational dual agonist of the glucagon and GLP-1 receptors.

  • Cagrilintide

    Investigational

    GLP-1 & weight-loss peptides · Early or small human studies

    An investigational long-acting analogue of amylin, a hormone released with insulin that helps you feel full.

Other collections